• Profile
Close

Prognostic impact of missed chemotherapy doses during chemoradiation therapy for non–small cell lung cancer

American Journal of Clinical Oncology Mar 29, 2018

Deek MP, et al. - Non–small cell lung cancer (NSCLC) patients treated with definitive chemoradiation therapy (CRT) were examined, to determine the prognostic impact of missed chemotherapy administrations (MCA). Findings demonstrated a correlation of MCA with worse prognosis and increased mortality. Methods to reduce toxicity may improve administration of all chemotherapy doses and increase overall survival in NSCLC treated with CRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay